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Myxoma virus (MYX) prevents apoptosis in RK-13 cells and forms thick dermal lesions with 100% mortality in rabbits. MYX encodes the
virulence factor SERP2, a serine proteinase inhibitor (serpin). SERP2 was mutated to evaluate SERP2 function during MYX infection.
MYXΔSERP2::lacZ (deleted for SERP2) did not inhibit apoptosis in RK-13 cells; infected rabbits had thin dermal lesions and <10% mortality.
MYX-SERP2-D294A, a P1-site aspartate to alanine mutant, inactivated the serpin; infection was indistinguishable from MYXΔSERP2::lacZ.
SERP2-D294E prevented inhibition of caspase-8, caspase-10 and granzyme-B; and MYX-SERP2-D294E failed to block apoptosis in RK-13 cells,
but was fully virulent in rabbits. MYXΔSERP2::crmA expressed crmA instead of SERP2 and inhibited apoptosis in cell culture, but caused thin
lesions and only 70% mortality in rabbits, hence crmA cannot fully substitute for SERP2. Control of apoptosis in culture does not correlate with
virulence in rabbits. Virulence may instead depend on inhibition of proinflammatory proteinases by SERP2.
© 2006 Elsevier Inc. All rights reserved.Keywords: Myxoma virus; Poxvirus; Serpin; Proteinase; Protease; Caspase; Apoptosis; Inflammation; Pathogenesis; VirulenceIntroduction
Myxoma virus (MYX) is a poxvirus within the genus Le-
poripoxvirus. The Lausanne strain of MYX causes lethal
infection in European rabbits (Oryctolagus cuniculus) and is
transmitted mechanically by biting insects (Fenner and
Woodroffe, 1953). Poxviruses encode a variety of proteins
that can be considered virulence factors that are of interest
clinically because of their anti-inflammatory and anti-apoptotic
properties (McFadden and Murphy, 2000). One class of
poxvirus virulence factors are serine proteinase inhibitors⁎ Corresponding author. Fax: +1 352 273 5232.
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doi:10.1016/j.virol.2006.07.049(serpins). MYX encodes three serpins designated SERP1,
SERP2 and SERP3 (Cameron et al., 1999).
Serpins are found in all higher organisms, but poxviruses are
the only viruses that encode serpins that function as proteinase
inhibitors (Silverman et al., 2001). Inhibition of proteinase
activity occurs when proteinases recognize and cleave a scissile
bond (designated P1–P′) in the reactive center loop (RCL) of a
target serpin leading to a conformational change and formation
of a stable serpin/proteinase complex which renders the
proteinase inactive (Huntington et al., 2000). In addition to
acting as proteinase inhibitors, some serpins interact with
cellular components through regions of the serpin other than the
RCL. For example, antithrombin is a serpin that contains a
heparin binding site (Chang et al., 1996) located on the serpin
backbone rather than the RCL. The specificity of some serpin/
proteinase interactions is modified by secondary binding sites in
Fig. 1. Detection of serpin/proteinase inhibitory complexes using a gel-shift
assay. 35S-labeled proteins were expressed in vitro, incubated with varying
amounts of human granzyme B and evaluated by SDS–PAGE.
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established that directed mutation of serpins can lead to greater
understanding of serpin function. For example, mutation of the
P1-site of a serpin can alter the profile of proteinases inhibited
by the serpin (Holmes et al., 1987).
SERP2 from MYX and the cytokine response modifier A
(crmA) gene from the Orthopoxvirus Cowpox virus (CPV) are
poxvirus serpins that contain an aspartate at the P1-site in the
RCL. Overall, SERP2 and crmA have 34.9% identity at the
amino acid level, but 57.3% similarity (Petit et al., 1996). This
level of similarity is typical of that found across random
members of the serpin superfamily. However, because both
poxvirus serpins encode a P1-aspartate, they might be expected
to inhibit similar proteinases in vitro. In fact, SERP2 and crmA
are both cross-class inhibitors that inhibit proinflammatory and
pro-apoptotic cysteine aspartyl-specific proteinases (caspases)
(Petit et al., 1996; Garcia-Calvo et al., 1998) as well as the
serine proteinase granzyme B (Turner et al., 1999; Quan et al.,
1995).
Consistent with the ability of SERP2 to inhibit proinflam-
matory and pro-apoptotic proteinases in vitro, the presence of
SERP2 is reported to decrease inflammation and apoptosis
during intradermal MYX infection of New Zealand White
(NZW) rabbits (Messud-Petit et al., 1998). This group showed
that MYX deleted for SERP2 (MYXΔSERP2) caused dermal
lesions with increased mononuclear inflammation compared to
infection with MYX. Unlike lesions caused by MYX, the
lesions caused by MYXΔSERP2 were non-myxomatous.
Extensive apoptosis was observed in parotid lymph node
sections from rabbits infected with MYXΔSERP2 but not in
rabbits infected with MYX. Increased inflammation and
apoptosis did not affect the relative virus load in tissues infected
with MYXΔSERP2. Hence, SERP2 was thought to control and
inhibit inflammation and apoptosis in infected rabbits.
The effect of crmA deletion from CPV is also consistent with
the ability of crmA to inhibit proinflammatory and pro-apoptotic
proteinases. CrmA inhibits inflammation (Pickup et al., 1986)
and apoptosis (Nathaniel et al., 2004) in chicken chorioallantoic
membranes (CAMs) during CPV infection. In this model,
deletion of crmA from CPV causes a decrease in virus titer
(Palumbo et al., 1989). Virus yield correlates to the ability to
control apoptosis during infection of CAMs and is independent
of the presence or absence of inflammation (Nathaniel et al.,
2004).
To date, SERP2 and crmA inhibit the same proteinases in
vitro and both are thought to control inflammation and
apoptosis in animal models, however they do not fully
substitute for each other during infection. When crmA is
replaced by SERP2 during CPV infection of CAMs, SERP2 is
able to prevent apoptosis and restore virus yields, but it cannot
block inflammation (Nathaniel et al., 2004). Likewise, when
SERP2 is replaced by crmA during MYX infection of NZW
rabbits, crmA is able to partially restore virus virulence (with
a mortality rate of 70%), but it does not cause the
myxomatous lesions that are characteristic of MYX infection
(Nathaniel et al., 2004). This suggests that these two poxvirus
serpins (1) show species specificity in their ability to inhibitproteinases, (2) inhibit different, currently unidentified pro-
teinases or (3) have additional functions in vivo that do not
involve proteinase inhibition.
The goal of this project was to determine how SERP2
functions as a virulence factor during MYX infection of NZW
rabbits. Specific, single amino acid alterations were made at the
P1-site of SERP2 to determine the mechanism by which SERP2
functions as a virulence factor. SERP2 D294Awas created with
an alanine in place of aspartate at P1 and was expected to retain
the serpin structure but lack the ability to inhibit proteinases.
This mutation allowed us to assess the role of proteinase
inhibition mediated by SERP2 in virulence and disease. SERP2
D294E replaced the SERP2 aspartate at P1 with glutamate. This
mutation was chosen based upon the human serpin PI-9 which
contains a P1-glutamate. PI-9 inhibits granzyme B at a
physiologically significant rate (Bird et al., 1998); but PI-9
does not effectively inhibit caspase-1, caspase-3, caspase-4 or
caspase-8 (Annand et al., 1999). We had hoped that the SERP2
D294E mutation would allow us to assess the relative effect of
inhibiting granzyme B alone (without concurrent caspase
inhibition) during MYX infection of NZW rabbits. However,
we show that, rather than converting SERP2 into a selective
inhibitor of granzyme B, SERP2 D294E inhibited caspase-1 but
no longer inhibited granzyme B, caspase-8 or caspase-10.
Although SERP2 D294E did not behave as expected, MYX
SERP2 D294E allowed us to examine how controlling
inflammation without controlling apoptosis affected the patho-
genesis of MYX infection of rabbits.
Results
Complex formation between serpins produced in vitro and
human granzyme B
Altered SERP2 proteins with P1-site mutations were tested
for the ability to form a stable complex with granzyme B in vitro
using a gel-shift assay. 35S-methionine-labeled proteins pro-
duced by in vitro transcription and translation were incubated
with varying amounts of human granzyme B then analyzed on
an SDS–10% polyacrylamide gel (Fig. 1). For reference, crmA
is a 38 kDa protein (Palumbo et al., 1989) and SERP2 is a
Fig. 2. Progress curve analysis of caspase-1. Inhibition with purified SERP2
protein (A) and SERP2 D294E protein (B). A fixed amount of caspase-1 was
incubated either alone (filled diamonds) or in the presence of 250 ng (open
squares), 500 ng (triangles) or 1000 ng (crosses) of protein, and fluorescence
generated by cleavage of the substrate YVAD-AMC monitored over 12 h
(43,200 s). The initial portions of the curves up to 20,000 s are shown. The
degree of curvature, i.e. how quickly the final rate of substrate cleavage is
reached, reflects the apparent association rate ka, and the final rate allows the
apparent inhibition constant to be calculated.
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with granzyme B (≈28 kDa) to form a stable complex (Fig. 1,
lanes 2 and 3). SERP2 also formed a complex with granzyme B
(Fig. 1, lanes 5 and 6). SERP2 D294A (≈34 kDa, designed to
be non-inhibitory) complexed very weakly with granzyme B
when a large amount of granzyme B was present (Fig. 1, lane 8).
This may be due to a weak proteinase interaction with the
aspartate at the P7-site of the SERP2 RCL. SERP2 D294E,
originally designed to inhibit granzyme B but not caspases,
formed a stable complex with granzyme B when analyzed by a
gel-shift assay (Fig. 1, lanes 11 and 12).
Kinetic properties of in vitro serpin/protein interactions
The ability of SERP2, SERP2 D294A and SERP2 D294E to
effectively inhibit human granzyme B, caspase-1, caspase-8 or
caspase-10 was assessed. Fig. 2 is a progress curve analysis of
human caspase-1 with His-tagged SERP2 (Fig. 2A) and His-
tagged SERP2 D294E (Fig. 2B). Similar progress curves were
used to calculate inhibition constants (Ki) and/or association
constants (ka) between the proteinases and His-tagged serpins
expressed by the Vaccinia virus (VV) T7 system (Table 1).
Inhibition of the proteinase by the serpin is considered
significant at a KI <1 nM (Garcia-Calvo et al., 1998) or ka
>105 M−1 s−1 (Travis and Salvesen, 1983).
CrmA is a physiologically significant inhibitor of caspase-1
(Komiyama et al., 1994; Garcia-Calvo et al., 1998), caspase-8
(Zhou et al., 1997; Garcia-Calvo et al., 1998) and granzyme B
(Quan et al., 1995). SERP2 effectively inhibits caspase-1,
caspase-8 and granzyme B. SERP2 may also inhibit caspase-10
effectively (the Ki is just slightly >1 nM). SERP2 D294A was
not able to inhibit any of the proteinases tested at a
physiologically significant level, which was the expected effect
of the alanine substitution at P1 although a non-physiological
inhibition of caspase-10 was noted. On the other hand, the
results of SERP2 D294E interactions with human caspases and
granzyme B were unexpected. Like PI-9, SERP2 D294E could
not inhibit caspase-8 or caspase-10 at a physiologically
significant level. Unlike PI-9, SERP2 D294E was an effective
inhibitor of caspase-1 (Ki≈0.2 nM and ka≈4.5×104 M−1 s−1).
Despite the fact that a complex was observed between SERP2
D294E and granzyme B on a gel-shift assay (Fig. 1, lanes 11
and 12), the inhibition constant for the interaction of SERP2
D294E with granzyme B suggests that inhibition is not likely to
be physiologically significant (Ki ≈25 nM). Based on these
data, SERP2 D294E can be considered a more specific inhibitor
of the proinflammatory proteinase caspase-1.
Caspase activation in RK-13 cells infected with MYX or MYX
recombinant viruses
The ability of crmA and the SERP2 P1-site mutants to
substitute for SERP2 during MYX infection was assessed by
constructing MYX recombinants where SERP2 has been
replaced by crmA or one of the P1-site mutant SERP2 genes.
A SERP2 deletion mutant (encoding lacZ in place of SERP2)
was also examined. To ensure that the recombinant proteinswere expressed, rabbit kidney epithelial (RK-13) cells were
infected with the recombinant viruses and protein expression in
infected cell extracts was examined using immunoblots probed
with either a mouse anti-crmA monoclonal antibody or a rabbit
anti-SERP2 polyclonal antibody. Stable expression of crmA and
the SERP2 P1-site mutant proteins was observed at levels
comparable to the wild type protein (data not shown). No
SERP2 protein was detected from samples derived from cells
infected with MYXΔSERP2::lacZ.
The effects of infection with MYX recombinant viruses on
growth in cell culture were examined in RK-13 cells. No
observable difference in virus growth was observed in one-step
growth curves in any of the virus strains examined (data not
Table 1
Kinetic properties of in vitro serpin/proteinase interactions
Caspase-1 Caspase-8 Caspase-10 Granzyme B
105×ka (M
−1 s−1) Ki (nM) 10
5×ka (M
−1 s−1) Ki (nM) Ki (nM) Ki (nM)
CrmAa 170 0.01 3.0 <0.34 17 nd
SERP2 0.96 0.1 0.70 0.5 1.3 0.6
SERP2 D294A nd Inactive nd Inactive 200 Inactive
SERP2 D294E 0.45 0.2 0.01 7.4 200 25
nd=not determined.
a Garcia-Calvo et al., 1998.
15A.L. MacNeill et al. / Virology 356 (2006) 12–22shown). However, we did observe nuclear pyknosis in RK-13
cells infected with MYXΔSERP2::lacZ, MYX SERP2 D294A
or MYX SERP2 D294E suggesting that apoptosis was
occurring during infection with these viruses. To determine
the role of SERP2 in preventing apoptosis in RK-13 cells,
caspase activation in infected cells was detected by two
methods, FITC-VADfmk staining and DEVD-aminomethyl-
coumarin (AMC) cleavage.
FITC-VADfmk is an irreversible inhibitor of effector
caspases that are activated during apoptosis. If apoptosis occurs,
caspases are activated, FITC-VADfmk binds to the activated
caspases and is retained in the cell, and FITC staining within the
cell is observed. RK-13 cells were infected with MYX or MYX
recombinant viruses at a high multiplicity of infection
(moi=10). At 16 h post inoculation (pi), cells were stained
with 4′,6-diamidino-2-phenylindole (DAPI) to visualize nuclei
and with FITC-VADfmk (Fig. 3). Apoptosis (indicated by FITC
staining) was not observed during infection with MYX or
MYXΔSERP2::crmA but was seen during infection with
MYXΔSERP2::lacZ, MYX SERP2 D294A or MYX SERP2
D294E. The fact that crmAwas able to substitute for SERP2 to
block apoptosis in the context of MYX but SERP2 D294A and
SERP2 D294E could not strongly suggests that SERP2 inhibits
apoptosis during MYX infection of RK-13 cells because it
inhibits proteinases. These results are consistent with the kinetic
parameters summarized for SERP2 and crmA suggesting that
SERP2 and crmA inhibit caspase-8 and caspase-10 at
physiological conditions but the mutant SERP2 proteins do
not (Table 1).Fig. 3. FITC-VADfmk staining of apoptotic cells. Caspase-3 activation was indicaApoptosis in RK-13 cells was also detected by measuring
effector caspase activation during a time course of infection
using a DEVD-AMC cleavage assay (Fig. 4). RK-13 cells
were infected with MYX or MYX recombinant viruses
(moi=10). Cell extracts were collected at several time points
and incubated with the caspase substrate, DEVD-AMC.
Cleavage of the substrate by activated caspases releases
AMC, which can be detected fluorimetrically. MYX and
MYXΔSERP2::crmA were able to prevent caspase activation
as increased fluorescence was not detected. Increase in
fluorescence was detected in cells infected with MYXΔ-
SERP2::lacZ, MYX SERP2 D294A or MYX SERP2 D294E
consistent with activation of caspases in these infected cells.
These results agree with kinetics data and the results of FITC-
VADfmk staining. In addition, MYXΔSERP2::lacZ was
rescued to restore expression of SERP2 during MYX infection
and was able to prevent caspase activation detected by
cleavage of DEVD-AMC (data not shown). MYX SERP2
D294A was restored to MYXΔSERP2::lacZ and produced
blue foci when stained with X-gal.
The effect of SERP2 mutations on infection of New Zealand
White rabbits
New Zealand White rabbits were infected intradermally at
the lateral aspect of each thigh with 500 plaque forming units
(pfu) of MYX or MYX recombinant viruses (for a total virus
dose of 1000 pfu/rabbit). Infections with MYX SERP2 D294A
were done to determine the effects of eliminating proteinaseted by FITC staining in infected RK-13 cells 16 h post inoculation (moi=10).
Fig. 4. DEVD-AMC cleavage as a measure of induction of apoptosis. Activation
of terminal caspases was detected by release of AMC during a time course of
infection in RK-13 cells (moi=10).
16 A.L. MacNeill et al. / Virology 356 (2006) 12–22inhibition from SERP2. Comparative infections with MYX,
MYX SERP2 D294A and MYX SERP2 D294E theoretically
allow us to examine, based on the data of Figs. 3 and 4, the
relative importance of control of inflammation and apoptosis
during MYX infection in rabbits.Table 2
Selected clinical signs in rabbits infected intradermally with 1000 pfu of virus
Day post inoculation MYX MXYΔSERP2::lacZ MYX
1 Raised, red lesions at
the inoculation sites
began to develop
2 Red lesions at the
inoculation sites
began to develop
Red l
inocu
began
4
5 Raised, red lesions on
ear pinnae and mucus
membranes first developed
6 Nasal discharge, decreased
respiratory rate and fever
were first noted
Red lesions on ear
pinnae first
developed
Red l
pinna
Fever was first noted Decre
and fe
7 Nasal discharge and
decreased
respiratory rate were
first noted
Nasal
first n
8 4/11 rabbits needed
to be euthanized
9 6/7 remaining rabbits
needed to be euthanized
10 1/1 remaining rabbit
needed to be euthanized
1/10 rabbits needed
to be euthanized
0/6 ra
to be
Cumulative
mortality
100% (11/11) 10% (1/10) 0% (0As expected, MYX infection was lethal; all 11 rabbits
inoculated with MYX had to be euthanized due to respiratory
distress by day 10 pi. Severe respiratory distress leading to
euthanasia developed in only 1 of 10 rabbits infected with
MYXΔSERP2::lacZ and did not develop in any of the
animals infected with MYX SERP2 D294A. Unexpectedly,
disease caused by MYX SERP2 D294E caused 100% mortality
(8 rabbits). MYXΔSERP2::crmA infection was mildly atte-
nuated and caused severe respiratory distress necessitating
euthanasia in 7 of 10 infected rabbits. 100% mortality was
observed in rabbits infected with rescued viruses that expressed
SERP2.
Signs of disease reflected the severity of infection (Table 2).
The decrease in respiratory rate was most dramatic during
infection with MYX and MYX SERP2 D294E and was the
primary indicator for euthanasia of infected rabbits.
Mandibular lymph nodes, thymus and spleen were examined
to determine if control of apoptosis in RK-13 cells correlated to
control of apoptosis during infection of rabbits. All lymph
nodes examined with hematoxylin and eosin staining had
lymphoid hyperplasia and sinus histiocytosis with or without
edema. Apoptosis in mandibular lymph nodes, thymus and
spleen was assessed using terminal deoxynucleotidyl transfer-
ase-mediated dUTP nick-end labeling (TUNEL). No significantSERP2 D294A MYX SERP2 D294E MXYΔSERP2::crmA
Raised, red lesions at
the inoculation sites began
to develop
Red lesions at the
inoculation sites began
to develop
esions at the
lation sites
to develop
Raised, red lesions on ear
pinnae and mucus
membranes first developed
Red lesions on ear pinnae
and mucus membranes
first developed
esions on ear
e first developed
Fever was first noted Fever was first noted
ased respiratory rate
ver were first noted
discharge was
oted
Nasal discharge was
first noted
Nasal discharge
was first noted
Decreased respiratory
rate was first noted
1/8 rabbits needed to
be euthanized
1/7 remaining rabbits
needed to be euthanized
Decreased respiratory
rate was first noted
6/10 rabbits needed to
be euthanized
bbits needed
euthanized
6/6 remaining rabbits
needed to be euthanized
1/4 remaining rabbits
needed to be euthanized
/6) 100% (8/8) 70% (7/10)
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observed between different virus infections (data not shown).
This result differs from that earlier reported (Messud-Petit et al.,
1998).
There were also no significant differences in growth of the
virus in skin lesions from animals infected with either MYX or
MYX recombinant viruses based on virus titers recovered from
dermal lesions at late times during infection. Infection with
each virus yielded approximately 106 pfu per g of tissue from
both dermal lesions at the site of inoculation and from lesions
which develop on ear pinnae (data not shown). These data
agree with earlier observations (Messud-Petit et al., 1998).
Significant differences were observed in the morphology of
lesions caused by MYX recombinant viruses. The most striking
difference was in lesion thickness (Fig. 5).Mixedmodel analysis
of lesion thickness was conducted using PROC MIXED in SAS
9.1. All infected animals had significantly thicker lesions than
PBS inoculated controls (p values<0.0001). Animals infected
withMYX orMYXSERP2D294E viruses had lesions that were
significantly thicker than lesions in animals infected with
MYXΔSERP2::lacZ, MYX SERP2 D294A or MYXΔSERP2::
crmA (p values≤0.01). Lesion thickness correlated extremely
well with the amount of edema observed histologically.
Representative photographs taken at day 10 pi of dermal
lesions at the site of virus inoculation as well as lesions from
the ears of rabbits and histology sections of the lesions at the
site of inoculation are shown in Fig. 6. MYX and MYX
SERP2 D294E infections were indistinguishable. Both viruses
caused large, thick, raised, myxomatous lesions at the site of
virus inoculation that became necrotic by day 5 or 6 pi (Figs.
5 and 6B). Extensive, thick, raised and myxomatous lesions
were observed on the ears (Fig. 6A), eyes, nose and anus withFig. 5. Lesion-integument thickness. The thickness of the lesion at the site of
inoculation on the thigh of infected rabbits was measured with calipers at
necropsy. Error bars show the standard deviation of the lesion thickness.both viruses. In contrast, MYXΔSERP2::lacZ, MYX SERP2
D294A and MYXΔSERP2::crmA caused lesions at the site of
inoculation that were large, but thin and non-myxomatous
with necrotic centers at day 5 or 6 pi (Figs. 5 and 6B). Lesions
on the ears (Fig. 6A) and mucus membranes were also thin
and non-myxomatous during infection with MYXΔSERP2::
lacZ, MYX SERP2 D294A or MYXΔSERP2::crmA. How-
ever, the lesions on the ears of rabbits infected with
MYXΔSERP2::lacZ and MYX SERP2 D294A were signifi-
cantly smaller in diameter and were less severe than lesions on
rabbits infected with MYXΔSERP2::crmA. Note that the size
of the secondary lesions does not reflect the comparable levels
of virus recovered per g of tissue collected from a given
lesion.
Histological sections of lesions from MYX and MYX
SERP2 D294E infected animals had ischemic necrosis with
severe heterophilic inflammation (Fig. 6C, closed arrows)
within necrotic tissue and mononuclear inflammation surround-
ing the damaged area. Giant reactive fibroblasts (myxoma cells;
Fig. 6C, open arrows) and severe edema were predominant
features in MYX and MYX SERP2 D294E lesions. Myxoma
cells and edema were absent from MYXΔSERP2::lacZ, MYX
SERP2 D294A and MYXΔSERP2::crmA lesions; and the
inflammatory infiltrate was primarily mononuclear (Fig. 6C,
circles). Lesion thickness correlated well with the amount of
edema observed on histology (Figs. 5 and 6C).
Discussion
The abrogation of proteinase inhibition by altering the
P1-aspartate of SERP2 to alanine was as expected; SERP2
D294A could not effectively inhibit human granzyme B,
caspase-1, caspase-8 or caspase-10, all of which are normally
inhibited by SERP2. The SERP2 D294A mutation presumably
allows any inflammatory activity mediated by caspase-1 to
occur and does not prevent apoptosis mediated by pro-
apoptotic caspases or granzyme B. MYXΔSERP2::lacZ and
MYX SERP2 D294A both led to apoptosis of infected RK-13
cells and indistinguishable infections in rabbits. Data indicate
that an active P1-site in SERP2 is required for MYX virulence
and suggest that SERP2 functions solely as a proteinase
inhibitor during MYX infection. If other domains of the SERP2
protein have additional functions, unrelated to proteinase
inhibition, they do not play a role in virulence during infection
of rabbits.
The kinetic parameters for wild type SERP2 protein (Table 1)
were calculated by progress curve analysis, and the Ki value of
0.1 nM for SERP2 against caspase-1 is substantially lower than a
previous estimate of 80 nM obtained from a simpler analysis of
residual enzyme activity after adding different amounts of SERP2
protein, which assumed that the concentration of bound inhibitor
was negligible relative to the concentration of total inhibitor
(Turner et al., 2000). The earlier estimate of the Ki of SERP2 for
caspase-1 did not take into account the fact that the proportion of
active serpin was only 9%. The values for SERP2 against human
caspase-1 of ka=9.6×10
4 M−1 s−1 and Ki=0.1 nM indicate that
SERP2 is a more efficient caspase-1 inhibitor than previously
Fig. 6. Lesions from rabbits infected by intradermal inoculation of 500 pfu of virus on the lateral aspect of each thigh. Lesions were evident on ear pinnae by day 10
post inoculation (A). Large lesions were observed at the site of virus injection at day 10 post inoculation (B). Histopathology sections (H&E, 400×) are representative
of an area of tissue from the virus inoculation site just outside of the necrotic center of the lesion (C). Myxoma cells are indicated by open arrows. Note the increased
space between myxoma cells (indicative of edema). Open arrows indicate selected heterophils. Selected mononuclear cells are circled.
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ka=1.7×10
7 M−1 s−1 and Ki =0.01 nM (Garcia-Calvo et al.,
1998). Nevertheless, our results studying infection of NZW
rabbits suggest that SERP2 leads to a more virulent disease than
does crmA. If the sole function of the two serpins is to inhibit
proteinases, then SERP2 could be better adapted to interact with
rabbit proteinases than is crmA.
SERP2 D294E had an unexpected inhibitory profile. Based
upon the serpin PI-9 literature (Bird et al., 1998; Annand et al.,
1999), we predicted that SERP2 D294E would effectively
inhibit granzyme B, but not caspases (a pattern observed with
PI-9). Instead, SERP2 D294E inhibited human caspase-1 but
was ineffective at inhibiting granzyme B. However, like PI-9,
SERP2 D294E could not effectively inhibit caspase-8 or
caspase-10, consistent with the induction of apoptosis during
infection of RK-13 cells with MYX SERP2 D294E. It is clear
that serpin specificity depends on more than the P1-site in the
serpin RCL alone.
In contrast to what we observed during infection of rabbit
kidney epithelial cells, MYXΔSERP2 did not lead to
apoptosis in infected rabbit RL5 CD4+ T cells and no
apoptosis was observed after stimulating HeLa cells infected
with MYXΔSERP2 with tumor necrosis factor-α (Messud-
Petit et al., 1998). The ability to observe the anti-apoptotic
function of SERP2 in RK-13 cells but not lymphocytes may
be due to differences in the cellular response to virusinfection within different cell types. The presence of SERP2 is
likely to be more important during natural infection of MYX
after an insect bite through the skin where epithelial cells
predominate.
All rabbits inoculated with virus had mild to moderate,
diffuse, primarily mononuclear, interstitial pneumonia. There
were some animals in each experimental group that also had
pulmonary edema, hemorrhage and congestion. The severity
of the inflammatory infiltrate did not correlate with the
severity of clinical disease (data not shown). The only
bacterium isolated from lung tissue of the specific-pathogen-
free rabbits was Bordetella bronchiseptica, which is present
in the normal flora of the respiratory tract of rabbits. The
bacterium grew to similar levels in both uninfected and
infected rabbits. This finding indicates that the rabbits did not
die of secondary bacterial pneumonia, which has been
reported in rabbits that are not maintained in a specific-
pathogen-free environment (Fenner and Woodroffe, 1953).
The lack of distinct histopathological differences in the
severity of lung lesions among experimental groups was
striking and suggests that respiratory distress was due to
presence of lesions in the mucus membranes of the upper
respiratory tract and nose.
The most striking difference in pathogenesis of the less
virulent MYX recombinant viruses was the lack of myxoma
cell formation and edema that is seen with MYX and MYX
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crmA, MYXΔSERP2::lacZ and MYX SERP2 D294A caused
mononuclear inflammation rather than the predominately
heterophilic response observed with MYX and MYX SERP2
D294E. It is probable that heterophilic inflammation and
release of toxic mediators from heterophils lead to damage of
surrounding tissue and cause fibroblast reactivity (myxoma cell
formation) and severe edema. It is also likely that mononuclear
cells are more effective at preventing virus spread than
heterophils.
Messud-Petit et al. (1998) reported that deletion of SERP2
from MYX caused increased apoptosis in parotid (mandibu-
lar) lymph nodes. We were unable to detect increased
apoptosis in animals infected with MYXΔSERP2::lacZ in
the lymphoid organs we examined. Rabbits infected with wild
type and recombinant MYX viruses had similar levels of
apoptotic cells in the mandibular lymph nodes, thymus and
spleen as measured by TUNEL staining. This discrepancy
may be due to differences in study designs. Messud-Petit et
al. (1998) injected 8-week-old male rabbits intradermally in
the right ear with 5000 pfu of virus per rabbit, whereas we
injected 8-week-old female specific-pathogen-free rabbits
intradermally in the thigh with 1000 pfu of virus per rabbit.
The fact that the mandibular lymph nodes drain the
inoculation site (the ear) in the experiments by Messud-Petit
et al. (1998) may be the reason that they observed a
difference in control of apoptosis in lymph nodes and we did
not. However, since myxomatosis is a systemic disease
process, one might expect all lymphoid organs to be similarly
affected at the end stages of disease due to draining of the
secondary lesions by the lymph nodes.
Although the SERP2 D294E mutant did not behave in vitro
as we had anticipated, the mutation removed the ability of
SERP2 to block apoptosis in cell culture, without affecting
virulence in rabbits. This finding, together with the inhibition of
caspase-1 by SERP2 D294E (Table 1), suggests that the primary
role of SERP2 during MYX infection is to control inflammation
rather than apoptosis.
We wish to make note of an unexpected finding (unrelated
to our results per se) linked to the use of the dominant
selectable eco-gpt marker (Falkner and Moss, 1988) to
generate one of our virus strains. The construction of
recombinant viruses MYX SERP2 D294A and MYX
SERP2 D294E was initially achieved using transient
dominant selection (Falkner and Moss, 1990). This method
of generating recombinant poxviruses has been used success-
fully in virulence studies with VV infection of mice (Kettle et
al., 1995) and MYX infection of rabbits (Messud-Petit et al.,
1998). The desired mutation in SERP2 was readily obtained
by this technique. However, when the reconstructed wild type
(wt) MYX virus derived from MYX SERP2 D294A was
evaluated in animals, it was found to be less virulent than
typical wt MYX suggesting that, in this particular construct,
an additional unexpected mutation elsewhere in the MYX
genome occurred. This finding was repeated with a second
independent preparation of MYX SERP2 D294A. The MYX
SERP2 D294E virus behaved as expected. This unknownsecondary mutation(s) in MYX SERP2 D294A affects only in
vivo infections. As a consequence of this problem, we
constructed virus mutants using lacZ which allowed recom-
binant viruses to be visualized in the absence of selective
pressure. We feel that our results with transient dominant
selection illustrate the need to test reconstructed wt virus
controls produced from any given mutant to ensure that no
secondary mutations have arisen. It is possible that any
commonly used selection technique may on occasion,
unpredictably fail in the sense of producing unintended
mutations depending on the exact constructs being prepared.
Additional studies with purified SERP2, SERP2 mutant
proteins and crmA are warranted to further elucidate the
functions of these proteins. Key information to determine
would be the species specificity of proteinase inhibition by
SERP2 and crmA against rabbit enzymes, which can only be
obtained when caspases and granzyme B from the rabbit
become available. The in vivo proteinases inhibited by SERP2
are inferred from in vitro data but are not proven. This
information would not only add to knowledge about poxvirus
serpin function, but would lead to a better understanding of
poxvirus pathogenesis and the host immune response to
poxvirus infection.Materials and methods
Site directed mutagenesis of SERP2
To create single amino acid mutations in SERP2, the SERP2
gene was subcloned from pGEM-5Zf(+) SERP2 into the
pALTER-Ex1 vector supplied with the Altered Sites Mutagen-
esis System (Promega, Madison, WI) using NcoI and NdeI.
This vector is designed to express mutant proteins driven by the
T7 RNA polymerase promoter. The oligonucleotide used to
create SERP2 with alanine in place of aspartate at amino acid
294 of SERP2 (SERP2 D294A) was GGATGTGTTA-
CGGCCTTTGGTGGTACGATG, which contains a HaeIII
restriction enzyme site (underlined). The oligonucleotide
GGATGTGTTACAGAATTCGGTGGTACGATG was made
to replace SERP2 P1-aspartate with glutamate (SERP2
D294E); it contains an EcoRI restriction enzyme site (under-
lined). Plasmid DNA was screened for the wanted mutation by
restriction enzyme digestion with HaeIII or EcoRI. Plasmids
were sequenced using the forward sequencing primer FS 133 T7
(AATACGACTCACTATAG) and the reverse sequencing
primer FS 190 (CAGGAAACAGCTATGAC). No unwanted
mutations were present.
Plasmids were then altered to encode gpt, which allows for
transient dominant selection of virus recombinants (Falkner and
Moss, 1988). A DNA fragment containing a poxvirus promoter
(P7.5) followed by gpt was subcloned from pBluescript gpt L
into three plasmids (pALT-Ex1 SERP2, pALT-Ex1 SERP2
D294A and pALT-Ex1 SERP2 D294E) using NdeI and HindIII.
Correct placement of P7.5-gptwas confirmed by sequencing the
plasmids using primers FS 133 T7 and FS 190. In vitro
transcription and translation were done to be sure protein
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altered by the insertion of P7.5-gpt.
In vitro transcription and translation of protein
SERP2 and SERP2 P1-site mutant proteins labeled with
35S-methionine were expressed from pALTER-Ex1 plasmid
constructs in the TNT T7 Quick Coupled Transcription/
Translations System (Promega, Madison, WI) as directed.
Proteins were visualized by autoradiography of SDS–10%
polyacrylamide gels enhanced with Amplify (Amersham
Pharmacia Biotech, Inc., Piscataway, NJ).
Serpin/Granzyme B interactions
The enzymatic and gel-shift assays using granzyme B were
described previously (Turner et al., 1999). The one exception to
the published protocols was the use of purified human
granzyme B instead of mouse granzyme B.
Determination of kinetic parameters by the progress curve
method
Purified SERP2, SERP2 D294A and SERP2 D294E proteins
with a His10 tag appended at the N-terminus were obtained by
constructing VV recombinants with the gene under the control
of the T7 promoter and co-infecting HeLa suspension cells with
each VV-PT7-SERP2 recombinant and with vTF7-3 expressing
the T7 RNA polymerase, as previously described for SERP2
(Turner et al., 1999). The tagged proteins were purified by
immobilized metal affinity chromatography and were homo-
geneous based on Coomassie stained SDS–acrylamide gels.
SERP2 and the D294A and D294E derivative proteins were
quantified by the Bradford assay.
Caspase buffer (100 mMHEPES, pH 7.5; 10% sucrose; 0.1%
CHAPS, 10 mM dithiothreitol) was used throughout for assays
with caspase-1, caspase-8 and caspase-10. For granzyme B
assays, the buffer was 0.1 MHEPES, pH7.5; 10 mMCaCl2. The
fluorogenic substrates for granzyme B, caspase-1, caspase-8 and
caspase-10, together with the experimentally determined Km
values in parentheses, were: granzyme B, IETD-AFC
(44.6 μM); caspase-1, YVAD-AMC (24.2 μM); caspase-8,
IETD-AFC (18.3 μM); caspase-10, LEHD-AMC (19.9 μM).
The active site concentration of purified caspase-1 was
determined by titration with the irreversible inhibitor Z-
VADfmk (Stennicke and Salvesen, 2000). The proportion of
active SERP2 protein was measured by incubating different
amounts with a fixed quantity (0.7 pmol) of active site-titrated
caspase-1 for 3 h and determining by extrapolation how much
was required for complete inhibition. SERP2 protein was
approximately 9% active by this criterion.
The inhibition constant Ki and where possible the association
rate ka were determined by progress curve analysis (Turner et
al., 2000). A fixed low amount of enzyme that gave a linear rate
of substrate cleavage over a 12 h period was incubated either
alone in triplicate or with different concentrations of SERP2,
SERP2 D294A or SERP2 D294E.Cells
Rabbit kidney epithelial cells (RK-13 cells) were obtained
from the American Type Culture Collection (ATCC CCL-37)
and were maintained in supplemented media (minimum
essential medium (MEM) with Earle's salts plus 5% fetal
bovine serum, 2 mM glutamine, 50 U/mL penicillin G,
50 μg/mL streptomycin, 1 mM sodium pyruvate and 0.1 mM
nonessential amino acids). MEM with Earle's salts and fetal
bovine serum (FBS) were obtained from GIBCO, Grand
Island, NY. Other supplements were purchased from Media-
tech, Herndon, VA. Tissue cultures were maintained at 37 °C
in 5% CO2.
Virus
The Lausanne strain of Myxoma virus (MYX) was obtained
from Grant McFadden (Robarts Research Institute, London,
Ontario, Canada). MYX can also be acquired from the ATCC
(VR-115). MYXΔSERP2::lacZ and MYXΔSERP2::crmA
construction was described previously (Nathaniel et al., 2004).
MYX SERP2 D294E was isolated using transient dominant
selection (Falkner and Moss, 1988) by transfecting pALT-Ex1
SERP2 D294E gpt plasmid DNA into RK-13 cells infected with
MYX. Viruses containing gpt were selected in supplemented
media plus 5 μg/mL mycophenolic acid, 250 μg/mL xanthine
and 15 μg/mL hypoxanthine (Sigma Chemicals, St. Louis,
MO). Viruses were passaged in supplemented media without
additional additives. Virus DNA was extracted for PCR and
restriction enzyme digestion to verify the presence of the
desired mutation in SERP2. Production of SERP2 D294E by the
virus was confirmed by Western immunoblotting using a rabbit
anti-SERP2 polyclonal antibody. The sequence of MYX SERP2
D294E from approximately 300 base pairs (bp) upstream of the
SERP2 open reading frame (ORF) to approximately 300 bp
downstream of the SERP2 ORF contained no unwanted
mutations.
MYX SERP2 D294A was constructed without transient
dominant selection because two attempts to isolate MYX
SERP2 D294A using transient dominant selection produced
viruses that contained additional, unwanted mutations some-
where else in the MYX genome. RK-13 cells were infected with
MYXΔSERP2::lacZ (which had previously been constructed
from MYX and rescued successfully using transient dominant
selection). Infected cells were transfected with a PCR fragment
that contained SERP2 D294A plus approximately 300 bp of
MYX sequence 3′ and 5′ of the gene. The virus was collected,
plaqued and incubated for 7 days. Supplemented media plus 5%
FBS and 300 μg/mL X-gal (Gold Biotechnologies Inc., St.
Louis, MO) were placed on the overlay overnight. White
plaques were isolated and purified. SERP2 D294A plus
approximately 300 bp surrounding the gene was PCR
amplified, and the genotype of the viruses was verified by
sequencing. Protein expression was confirmed with a Western
immunoblot using a rabbit anti-SERP2 polyclonal antibody.
MYX SERP2 D294A was restored to MYXΔSERP2::lacZ
without transient dominant selection. A PCR fragment
21A.L. MacNeill et al. / Virology 356 (2006) 12–22containing lacZ surrounded with MYX sequence just outside of
the 5′ and 3′ ends of SERP2 was transfected into cells infected
with MYX SERP2 D294A and a SERP2 deletion mutant
expressing lacZ was isolated.
Virus titering
MYX and MYX recombinant viruses were titered in RK-13
cells. Titers were expressed as plaque forming units of virus per
milliliter (pfu/mL). Plaques formed by MYX were small white
foci that were counted by eye without staining. Tissue collected
from animals was flash-frozen in liquid nitrogen and stored at
−80 °C until it was titered. Tissues were weighed, and 1 mL of
PBS was added to each sample. Approximately 0.75 mL of
1.0 mm diameter zirconia beads (Biospec Products, Inc.,
Barlesville, OK), acid-washed sand (Ocala, FL) or 24-grit SiC
(Electro abrasives, Buffalo, NY) was added to each tube.
Tissues were disrupted using a MiniBeadbeater-8 (BioSpec
Products, Inc., Bartlesville, OK). Cells were inoculated with
diluted organ samples, and virus titers were determined. In
addition, all samples were stained overnight with supplemented
media plus 300 μg/mL of X-gal. Virus plaques isolated from
animals infected with virus lacking lacZ always remained
white. Plaques isolated from animals infected with virus
encoding lacZ always stained blue with X-gal.
Virus sequencing
Sequencing reactions were done using the ABI PRISM
BigDye Terminator Cycle Sequencing Ready Reaction Kit
(Perkin-Elmer, Foster City, CA) with either Taq polymerase or
VENT DNA polymerase (New England Biolabs Inc., Ipswich,
MA). The product was purified using Edge Biosystems AGTC
Filtration Cartridges (Edge Biosystems, Gaithersburg, MD) and
then desiccated. Sequences were analyzed by the University of
Florida Interdisciplinary Center for Biotechnology Research
DNA Sequencing Core.
Caspase inhibitor-fluorochrome binding assay
Visualization of apoptotic cells was done using FITC-
VADfmk and counterstaining with DAPI. FITC-VADfmk is a
caspase inhibitor that binds to activated terminal caspases and
is labeled with a fluorochrome. Cells were grown to 80%
confluence and then infected with virus at an moi of 10. Virus
was adsorbed for 1 h at 37 °C, with rocking. The virus
inoculum was removed, and cells were washed in supple-
mented media without serum then incubated in 400 μL of
supplemented media for 16 h at 37 °C. Cells were washed in
PBS and then stained with 5 μM CaspACE FITC-VADfmk In
Situ Marker (Promega, Madison, WI) for 90 min at room
temperature. Cells were fixed in 1% paraformaldehyde for
20 min. Cells were then washed in PBS and stained with
0.1 μg/mL DAPI in PBS plus 0.1% Saponin for 30 min at
room temperature. Photographs of the stained infected cells
were taken using a fluorescent microscope equipped with a
digital camera.Caspase substrate-fluorochrome cleavage assays
DEVD-AMC cleavage assays were done to detect terminal
caspase activation in infected RK-13 cells. Cells in 35 mm
diameter dishes were infected at an moi of 10 and harvested at
various time points post infection. Harvested cells were pelleted
at 500×g for 5 min and washed in PBS. The cell suspension
was centrifuged at 500×g for 5 min and the supernatant was
removed. The pellet was resuspended in 100 μL of caspase-3
extract buffer (10 mM HEPES pH 7.5, 2 mM EDTA, 0.1%
CHAPS, 1 mM fresh DTT). The cell suspension was freeze/
thawed 4 times in a dry ice/EtOH bath. The pellet was spun at
5000×g for 15 min at 4 °C.
A Bradford assay was used to determine the total protein
concentration of the supernatant. Five micrograms of protein
was added to an opaque 96-well plate. The appropriate amount
of caspase-3 extract buffer was added to bring the total volume
of fluid in each well to 50 μL. Then, each well was filled with
150 μL caspase-3 extract buffer plus 0.01 mM DEVD-AMC
(Biomol Research Labs, Inc., Plymouth Meeting, PA). The rate
of cleavage of the caspase substrate was detected using a Tecan
SpectroFluor microplate reader (Tecan US Inc., Research
Triangle Park, NC) with an excitation wavelength of 360 nm
and an emission wavelength of 465 nm.
Intradermal inoculation of rabbits
All animal procedures were approved by the University of
Florida Institutional Animal Care and Use Committee. Eight to
nine-week-old, female, specific-pathogen-free NZW rabbits
were infected with MYX or MYX recombinant viruses as
previously described (Nathaniel et al., 2004), with one
exception. Blood was collected from the lateral saphenous
vein rather than by cardiac puncture. Briefly, the lateral aspects
of the rabbits' thighs were surgically prepared and 500 pfu virus
in 0.1 mL PBS was injected intradermally into both thighs.
Rabbits were euthanized if signs of respiratory distress were
observed or by 11 days post inoculation.
Tissue samples
A complete necropsy was done after the rabbits were
euthanized. Samples were collected for histopathology, immu-
nohistochemical staining, bacterial culture and virus isolation.
Samples for histopathology were collected routinely and
placed in 10% buffered formalin. Samples used for immuno-
histochemistry were placed in cassettes in 95% ethanol
between 24 and 30 h after collection in 10% buffered formalin.
Samples were embedded and sectioned in the histopathology
laboratory at the University of Florida College of Veterinary
Medicine and stained with hematoxylin and eosin when
appropriate. Lungs that were not being used for bacterial
culture or virus isolation were expanded with 10% buffered
formalin at the time of collection. Lung samples used for
bacterial culture were collected using sterile techniques, placed
in sterile tubes, placed on ice and brought to the clinical
microbiology laboratory at the University of Florida College of
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Organs collected for determination of virus titer were flash-
frozen in liquid nitrogen and stored at −80 °C until they were
processed.
Terminal Deoxynucleotidyl Transferase (TdT) Mediated
dUTP Nick-End Labeling (TUNEL) immunohistochemical
assays were done on lymphoid tissue of rabbits infected
intradermally. The Apoptosis Detection System, Fluorescein
(Promega, Madison, WI) was used on rabbit tissue following
the manufacturer's directions for pretreatment of paraffin-
embedded tissues.
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